Home RxNorm 1233711 alpha 1-proteinase inhibitor, human 1 MG Injection [Aralast] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1233711
RxNorm name alpha 1-proteinase inhibitor, human 1 MG Injection [Aralast]
Display name alpha 1-proteinase inhibitor, human 1 MG Injection [Aralast]
Full name alpha 1-proteinase inhibitor, human 1 MG Injection [Aralast]
Term type SBD
Status DailyMed mapping
Updated 2026-06-04 23:39:14 Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125039 Aralast, Aralast Np Alpha-1-Proteinase Inhibitor (Human) 351(a) Rx 2026-07-01
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective a9a5b46e-04da-41bd-bb5f-c4936b664fef Aralast NP 1 MG Injection [PSN] · alpha 1-proteinase inhibitor, human 1 MG Injection [Aralast] [SBD] · Aralast 1 MG Injection [SY] 3 20 These highlights do not include all the information needed to use ARALAST NP safely and effectively. See full prescribing information for ARALAST NP. ARALAST ® NP (Alpha 1 -Proteinase Inhibitor (Human)) For Intravenous Use. Lyophilized Powder for Solution for Injection Initial U.S. Approval: 2002 20251125